A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Allergenicity of a whey hypoallergenic formula in genetically at risk babies: four case reports
European Review for Medical and Pharmacological Sciences
Hydrolysate formulas (HF) have been developed with the goal of reducing the allergenicity of cow's milk (CM) proteins, thus providing a suitable formula for feeding babies with CM allergy (CMA). More recently, whey HFs have provoked 208 reactions in babies at high risk of atopy when given for CMA prevention. We report the clinical and immunologic findings of four babies apparentlly sensitized by a partially whey hydrolysate formula (PWHF) in the nursery. They were exclusively BM (breast
pmid:16080638
fatcat:qcc32m27bvcpfomtz673doijc4